Literature DB >> 16981899

Adrenal axis suppression unrelated to the dynamics of dosing with beclomethasone monopropionate.

Siobhan A Mulrennan1, Joseph S Hogg, Richard C Teoh, Alyn H Morice.   

Abstract

AIMS: Inhaled corticosteroids (ICS) are the cornerstone of asthma treatment. At high doses they can give rise to systemic side-effects such as hypothalamic-pituitary-adrenal (HPA) axis suppression. This effect may depend on the delivery system, which in turn alters drug deposition and adsorption. We hypothesized that adrenal suppression depends on the rate of steroid absorption rather than the total steroid dose received.
METHODS: Eight healthy adult males were recruited for a randomized double-blind placebo controlled trial. Adrenocortical suppression ability was demonstrated by a 30% suppression of early morning cortisol following 1 mg dexamethasone. Subjects then attended in the evening on two occasions receiving 500 microg of intravenous beclomethasone monopropionate (17-BMP) for either 15 min or 2 h. Overnight urinary cortisol : creatinine (C : C) ratio was measured before and after the infusion and an 08.00 h serum cortisol was measured following the infusion.
RESULTS: Mean C : C pre and post 15 min infusion was 5.97 and 3.22 (P = 0.005). Mean C : C pre and post 2 h infusion was 6.31 and 4.15 (P = 0.004). Delta C : C and mean 08.00 h cortisol for 15 min and 2 h infusion was 2.74 and 2.16 and 425 nmol l(-1) and 400 nmol l(-1), respectively (P = NS).
CONCLUSIONS: The rate of infusion of 17-BMP seemed to have little effect on the degree of adrenal suppression. Individual C : C ratios were reproducible. Differences in absorption of ICS are unlikely to explain observed differences in HPA axis suppression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16981899      PMCID: PMC2000730          DOI: 10.1111/j.1365-2125.2006.02765.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Inhaled corticosteroids and the hypothalamic-pituitary-adrenal (HPA) axis: do we understand their interaction?

Authors:  P N Dekhuijzen; J W Honour
Journal:  Respir Med       Date:  2000-07       Impact factor: 3.415

2.  Corticosteroid complications in respiratory disease.

Authors:  F K Kwong; M A Sue; W B Klaustermeyer
Journal:  Ann Allergy       Date:  1987-05

3.  Affinities of glucocorticoids for glucocorticoid receptors in the human lung.

Authors:  P Rohdewald; H W Möllman; G Hochhaus
Journal:  Agents Actions       Date:  1986-01

4.  An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers.

Authors:  A Grahnén; S A Eckernäs; R M Brundin; A Ling-Andersson
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

5.  Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate.

Authors:  G Würthwein; P Rohdewald
Journal:  Biopharm Drug Dispos       Date:  1990-07       Impact factor: 1.627

6.  Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man.

Authors:  P T Daley-Yates; A C Price; J R Sisson; A Pereira; N Dallow
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

7.  A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids.

Authors:  Harold S Nelson; Wes Stricker; Thomas B Casale; Hershel Raff; Jon A Fourré; David C Aron; Kenneth B Newman
Journal:  J Clin Pharmacol       Date:  2002-03       Impact factor: 3.126

8.  Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.

Authors:  B J Lipworth
Journal:  Arch Intern Med       Date:  1999-05-10

9.  The midnight to morning urinary cortisol increment is an accurate, noninvasive method for assessment of the hypothalamic-pituitary-adrenal axis.

Authors:  W M Kong; J Alaghband-Zadeh; J Jones; G Carter; D O'Shea
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

10.  Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17 alpha,21-dipropionate in human liver and lung homogenate.

Authors:  P Andersson; A Ryrfeldt
Journal:  J Pharm Pharmacol       Date:  1984-11       Impact factor: 3.765

View more
  2 in total

1.  Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI.

Authors:  Dave Singh; Sara Collarini; Gianluigi Poli; Daniela Acerbi; Alessio Amadasi; Antonio Rusca
Journal:  Br J Clin Pharmacol       Date:  2011-12       Impact factor: 4.335

2.  The effect of an inhaled corticosteroid on glucose control in type 2 diabetes.

Authors:  John L Faul; Sandra R Wilson; James W Chu; James Canfield; Ware G Kuschner
Journal:  Clin Med Res       Date:  2009-02-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.